NuCana (NCNA) Long-Term Deferred Tax (2017 - 2025)
NuCana's (NCNA) quarterly Long-Term Deferred Tax came in at $155629.4 in Q4 2025, up 7.3% year-on-year from $145035.7 in Q4 2024, and down 6.23% quarter-over-quarter from $165971.5 in Q3 2025.
NuCana (NCNA) Long-Term Deferred Tax (2017 - 2025) Analysis & Trends
NuCana has disclosed Long-Term Deferred Tax across 9 years of filings, most recently posting $155629.4 for Q4 2025.
- Long-Term Deferred Tax for Q4 2025 came in at $155629.4, up 7.3% year-over-year; the trailing twelve-month figure through Dec 2025 was $155629.4 (up 7.3% YoY), and the FY2025 annual result was $154265.7, up 6.8% from the prior year.
- Long-Term Deferred Tax came in at $155629.4 for Q4 2025 at NuCana, down from $165971.5 in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $219581.7 in Q3 2024 to a low of $46871.8 in Q3 2021.
- The 5-year median for Long-Term Deferred Tax is $143219.9 (2023), against an average of $133044.1.
- Across the five-year window, Long-Term Deferred Tax surged 138.87% in 2022 and retreated 29.54% in 2025, its largest moves.
- NuCana's Long-Term Deferred Tax stood at $80880.6 in 2021, then soared by 49.37% to $120811.6 in 2022, then jumped by 46.91% to $177484.7 in 2023, then dropped by 18.28% to $145035.7 in 2024, then rose by 7.3% to $155629.4 in 2025.
- The last three Long-Term Deferred Tax figures came in at $155629.4 (Q4 2025), $165971.5 (Q3 2025), and $149413.1 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 155,629.45 |
| Sep 30, 2025 | 165,971.54 |
| Jun 30, 2025 | 149,413.12 |
| Mar 31, 2025 | 146,102.06 |
| Dec 31, 2024 | 145,035.71 |
| Sep 30, 2024 | 219,581.73 |
| Jun 30, 2024 | 212,053.09 |
| Mar 31, 2024 | 197,888.84 |
| Dec 31, 2023 | 177,484.72 |
| Sep 30, 2023 | 160,868.97 |
| Jun 30, 2023 | 141,404.04 |
| Mar 31, 2023 | 130,059.52 |
| Dec 31, 2022 | 120,811.62 |
| Sep 30, 2022 | 111,962.09 |
| Jun 30, 2022 | 100,745.14 |
| Mar 31, 2022 | 91,244.83 |
| Dec 31, 2021 | 80,880.64 |
| Sep 30, 2021 | 46,871.83 |
| Jun 30, 2021 | 51,715.95 |
| Mar 31, 2021 | 55,156.83 |